Speaker Profile
Biography
Abdulaziz Elgammal is Co-founder and Chief Product Officer of Proteinea, a biotechnology company combining artificial intelligence, computational biology, and experimental science to develop next-generation biotherapeutics. He helps advance Proteinea's AI-driven protein engineering platform, including Ankh, a protein language model designed to accelerate protein discovery and optimization. With a background in biomedical sciences from Zewail City of Science and Technology, Elgammal works at the intersection of biology, machine learning, and biotechnology entrepreneurship. His work focuses on applying advanced AI models to antibody engineering and therapeutic development, with the goal of making drug discovery faster and more effective.
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
Day 1 / Wed · Jan 27
Day 2 / Thu · Jan 28
Day 3 / Fri · Jan 29
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
